Alan G. Harris

6.6k total citations · 1 hit paper
134 papers, 5.0k citations indexed

About

Alan G. Harris is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Alan G. Harris has authored 134 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Epidemiology and 32 papers in Surgery. Recurrent topics in Alan G. Harris's work include Pituitary Gland Disorders and Treatments (57 papers), Neuroendocrine Tumor Research Advances (38 papers) and Growth Hormone and Insulin-like Growth Factors (32 papers). Alan G. Harris is often cited by papers focused on Pituitary Gland Disorders and Treatments (57 papers), Neuroendocrine Tumor Research Advances (38 papers) and Growth Hormone and Insulin-like Growth Factors (32 papers). Alan G. Harris collaborates with scholars based in United States, France and Denmark. Alan G. Harris's co-authors include George P. Chrousos, Domenic G. Iezzoni, Adrian Daly, Ilia J. Elenkov, Shereen Ezzat, Philippe Chanson, Kálmán Kovács, Gary Hattersley, Lorraine A. Fitzpatrick and Donald A. Redelmeier and has published in prestigious journals such as JAMA, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Alan G. Harris

132 papers receiving 4.8k citations

Hit Papers

Effect of Abaloparatide vs Placebo on New Vertebral Fract... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan G. Harris United States 38 1.9k 1.1k 1.1k 999 788 134 5.0k
Alberto Angeli Italy 50 4.2k 2.2× 2.9k 2.7× 540 0.5× 458 0.5× 1.4k 1.7× 209 8.3k
Sonia M. Najjar United States 39 925 0.5× 860 0.8× 1.0k 1.0× 2.0k 2.0× 722 0.9× 131 7.2k
Theodore J. Hahn United States 42 870 0.5× 719 0.7× 384 0.4× 646 0.6× 1.1k 1.5× 100 5.9k
Charles Kilo United States 42 1.7k 0.9× 857 0.8× 683 0.6× 1.6k 1.6× 210 0.3× 106 6.4k
Á Urbano-Márquez Spain 45 537 0.3× 398 0.4× 1.1k 1.1× 825 0.8× 129 0.2× 173 5.9k
Stephen F. Kemp United States 31 1.3k 0.7× 541 0.5× 126 0.1× 773 0.8× 187 0.2× 107 4.4k
Shuichi Okada Japan 42 1.0k 0.5× 1.7k 1.6× 1.3k 1.2× 1.3k 1.3× 649 0.8× 258 6.9k
Adriana Franzese Italy 32 1.2k 0.6× 778 0.7× 834 0.8× 619 0.6× 123 0.2× 151 3.8k
John J. Kelly United States 52 1.1k 0.6× 1.8k 1.7× 685 0.6× 1.4k 1.4× 739 0.9× 225 8.5k
Mogens Fenger Denmark 35 540 0.3× 497 0.5× 505 0.5× 822 0.8× 216 0.3× 130 3.8k

Countries citing papers authored by Alan G. Harris

Since Specialization
Citations

This map shows the geographic impact of Alan G. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Harris more than expected).

Fields of papers citing papers by Alan G. Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Harris. The network helps show where Alan G. Harris may publish in the future.

Co-authorship network of co-authors of Alan G. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Harris. A scholar is included among the top collaborators of Alan G. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Harris. Alan G. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Kevin, et al.. (2025). Conditioning Electrical Stimulation Fails to Enhance Sympathetic Axon Regeneration. Neurorehabilitation and neural repair. 39(7). 515–528.
2.
Rossum, Elisabeth F. C. van, Elçin Zan, Nicole Werner, et al.. (2023). Emerging diagnostic methods and imaging modalities in cushing’s syndrome. Frontiers in Endocrinology. 14. 1230447–1230447. 4 indexed citations
3.
Harris, Alan G., et al.. (2018). Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors. Neuropeptides. 68. 84–89. 8 indexed citations
5.
Meltzer, Eli O., Alfredo A. Jalowayski, Klaus Vogt, Domenic G. Iezzoni, & Alan G. Harris. (2006). Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial. Annals of Allergy Asthma & Immunology. 96(2). 363–368. 39 indexed citations
8.
Berkowitz, Robert, et al.. (1999). Mometasone Furoate Nasal Spray is Rapidly Effective in the Treatment of Seasonal Allergic Rhinitis in an Outdoor (Park), Acute Exposure Setting. Allergy and Asthma Proceedings. 20(3). 167–176. 50 indexed citations
9.
Kay, Gary G. & Alan G. Harris. (1999). Loratadine: a non‐sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clinical & Experimental Allergy. 29(S3). 147–150. 62 indexed citations
10.
Meltzer, Eli O., Alfredo A. Jalowayski, H.Alice Orgel, & Alan G. Harris. (1998). Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray. Journal of Allergy and Clinical Immunology. 102(1). 39–49. 103 indexed citations
11.
Harris, Alan G. & Adrian Daly. (1996). Acromegaly and its management. Open Repository and Bibliography (University of Liège). 12 indexed citations
12.
Harris, Alan G.. (1994). Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.. Gut. 35(3 Suppl). S1–S4. 224 indexed citations
13.
Harris, Alan G., et al.. (1994). Effect of octreotide on dynamic excretion of bile in Chinese acromegalic patients assessed by [99mTc]EHIDA hepatobiliary scan. Digestive Diseases and Sciences. 39(2). 284–288. 2 indexed citations
14.
Ezzat, Shereen, et al.. (1994). [13C]NMR studies of the effect of the somatostatin analogue octreotide on hepatic glycogenesis and glycogenolysis. Peptides. 15(7). 1223–1227. 2 indexed citations
15.
Chanson, Philippe, Bruce D. Weintraub, Alan G. Harris, & Albert Beckers. (1993). Treatment of TSH-secreting pituitary adenomas with octreotide : A floow-up of 52 patients. Open Repository and Bibliography (University of Liège). 1 indexed citations
16.
Laursen, Torben, Jens Otto Lunde Jørgensen, Hans Ørskov, et al.. (1993). Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients. European Journal of Endocrinology. 129(5). 399–408. 5 indexed citations
17.
Caroli‐Bosc, François‐Xavier, et al.. (1993). Endoscopic sphincterotomy for common bile duct calculi in patients without stones in the gallbladder. Digestive Diseases and Sciences. 38(12). 2225–2227. 4 indexed citations
18.
Binmoeller, Kenneth F., Alan G. Harris, R. Dumas, Chiara Grimaldi, & J Delmont. (1992). Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?. Gut. 33(8). 1129–1133. 79 indexed citations
19.
Harris, Alan G., et al.. (1990). Short Term Treatment of Acromegaly with the Somatostatin Analog Octreotide: The First Double-Blind Randomized Placebo-Controlled Study on Its Effects. The Journal of Clinical Endocrinology & Metabolism. 71(5). 1189–1194. 20 indexed citations
20.
Harris, Alan G.. (1982). 233. A New Method for Endocrine Cell Quantification in Intestinal Adaptation.. 117. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026